08.07.2019 • TopicsAsahi KaseiK 2019

Creating for Tomorrow - a New Concept Car

Asahi Kasei and GLM, an electric vehicle manufacturer, have completed a jointly developed concept car called AKXY showcasing a wide array of automotive-related materials and technologies from various Asahi Kasei businesses, focused on contribution to safety, comfort, and the environment.

Discussions and planning for the development of the concept car began in 2015. The car utilizes the electric vehicle platform of GLM to achieve a drivable design. The concept car has a design based on the SUV.

AKXY contains a variety of Asahi Kasei materials, components and systems. The car is also equipped with cutting-edge technology that has potential for commercialization in line with automotive industry trends for safe driving and accident prevention.

“We are very excited to unveil this concept car that embodies Asahi Kasei’s comprehensive capability to serve the automotive industry with innovative, high-value products. We believe it will spark many conversations with key customers on how we can help them enhance the safety, comfort, and environmental performance of their future vehicles.” – Hiroshi Yoshida, Senior Executive Officer
 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.